{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "National Clinical Research Center for Geriatric Diseases (Xiangya Hospital), Changsha, China",
    "The Royal Wolverhampton NHS Trust, Wolverhampton, UK",
    "Department of Radiation Oncology, Providence Portland Medical Center, Portland, Oregon, USA",
    "4Earle A. Chiles Research Institute, Portland, OR, USA",
    "Department of Pediatrics, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA",
    "Moores Cancer Center, La Jolla, CA, USA",
    "10Moores Cancer Center, La Jolla, CA, USA",
    "2UC San Diego Health, San Diego, CA, USA",
    "Earle A. Chiles Research Institute, Portland, OR, USA",
    "The Oregon Clinic, Portland, OR, USA",
    "Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA",
    "Providence Cancer Institute, Portland, OR, USA",
    "Moores Cancer Center, San Diego, CA, USA",
    "Department of Otolaryngology-Head and Neck Surgery, University of California San Diego School of Medicine, San Diego, CA, USA"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 20,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Hong Xiao"
    },
    {
      "affs": [
        1
      ],
      "name": "Ashish Patel"
    },
    {
      "affs": [
        2
      ],
      "name": "Marka Crittenden"
    },
    {
      "affs": [
        3
      ],
      "name": "Kristina Young"
    },
    {
      "affs": [
        4
      ],
      "name": "Ezra Cohen"
    },
    {
      "affs": [
        5
      ],
      "name": "Robert Saddawi-Konefka"
    },
    {
      "affs": [
        6
      ],
      "name": "Andrew Sharabi"
    },
    {
      "affs": [
        7
      ],
      "name": "J Silvio Gutkind"
    },
    {
      "affs": [
        8
      ],
      "name": "Alexandra Q Bartlett"
    },
    {
      "affs": [
        8
      ],
      "name": "Rom S Leidner"
    },
    {
      "affs": [
        8
      ],
      "name": "Brian D Piening"
    },
    {
      "affs": [
        9
      ],
      "name": "Steven Seung"
    },
    {
      "affs": [
        8
      ],
      "name": "Matthew H Taylor"
    },
    {
      "affs": [
        10
      ],
      "name": "Thomas M Duhen"
    },
    {
      "affs": [
        10
      ],
      "name": "Bernard A Fox"
    },
    {
      "affs": [
        10
      ],
      "name": "Alexa K Dowdell"
    },
    {
      "affs": [
        11
      ],
      "name": "Douglas A Hanes"
    },
    {
      "affs": [
        12
      ],
      "name": "Liza Blumenfeld"
    },
    {
      "affs": [
        13
      ],
      "name": "Joseph A Califano"
    },
    {
      "affs": [
        11
      ],
      "name": "Bryan R Bell"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/2yhtx7jd5smry.bib",
  "cited_by": 0,
  "doi": "10.1136/jitc-2026-sitc2026.0523",
  "fulltext_url": null,
  "id": "2yhtx7jd5smry",
  "issns": [
    "2051-1426"
  ],
  "landing_url": "https://doi.org/10.1136/jitc-2026-sitc2026.0523",
  "language": "en",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "RC254-282"
    ]
  ],
  "openalex": null,
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-04",
  "publisher": "BMJ Publishing Group",
  "ris": "https://research.draconitic.com/paper/2yhtx7jd5smry.ris",
  "sources": [
    {
      "first_seen": "2026-11-04T14:21:03Z",
      "native_id": "5b6751b0933c42358cf13af13a99f28d",
      "source": "doaj",
      "url": "https://doi.org/10.1136/jitc-2026-sitc2026.0523"
    }
  ],
  "subjects": [
    {
      "field": "biology",
      "origin": "journal-openalex:2403|Immunotherapy and Immune Responses",
      "subfield": "immunology"
    },
    {
      "field": "medicine",
      "origin": "lcc:RC254-282",
      "subfield": "oncology"
    }
  ],
  "title": "523 Lymphaticsparing neoadjuvant SABR and pembrolizumab (neo-ImmunoSABR) in HPVnegative HNSCC: results from a phase II multi-center trial with immune correlates",
  "title_text": "523 Lymphaticsparing neoadjuvant SABR and pembrolizumab (neo-ImmunoSABR) in HPVnegative HNSCC: results from a phase II multi-center trial with immune correlates",
  "type": "peer-reviewed",
  "updated_at": "2026-11-06T14:20:29Z",
  "url": "https://research.draconitic.com/paper/2yhtx7jd5smry",
  "venue": "Journal for ImmunoTherapy of Cancer",
  "versions": []
}